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Original Article
Acute hypoxia increases the cerebral
metabolic rate – a magnetic resonance
imaging study
Mark B Vestergaard1, Ulrich Lindberg1,
Niels Jacob Aachmann-Andersen2, Kristian Lisbjerg2,
Søren Just Christensen2, Ian Law3,4, Peter Rasmussen2,
Niels V Olsen2,5 and Henrik BW Larsson1,3
Abstract
The aim of the present study was to examine changes in cerebral metabolism by magnetic resonance imaging of healthy
subjects during inhalation of 10% O2 hypoxic air. Hypoxic exposure elevates cerebral perfusion, but its effect on energy
metabolism has been less investigated. Magnetic resonance imaging techniques were used to measure global cerebral
blood flow and the venous oxygen saturation in the sagittal sinus. Global cerebral metabolic rate of oxygen was
quantified from cerebral blood flow and arteriovenous oxygen saturation difference. Concentrations of lactate, glutam-
ate, N-acetylaspartate, creatine and phosphocreatine were measured in the visual cortex by magnetic resonance spec-
troscopy. Twenty-three young healthy males were scanned for 60min during normoxia, followed by 40min of breathing
hypoxic air. Inhalation of hypoxic air resulted in an increase in cerebral blood flow of 15.5% (p¼ 0.058), and an increase in
cerebral metabolic rate of oxygen of 8.5% (p¼ 0.035). Cerebral lactate concentration increased by 180.3% (p5 106),
glutamate increased by 4.7% (p5 104) and creatine and phosphocreatine decreased by 15.2% (p5 103). The N-
acetylaspartate concentration was unchanged (p¼ 0.36). In conclusion, acute hypoxia in healthy subjects increased
perfusion and metabolic rate, which could represent an increase in neuronal activity. We conclude that marked changes
in brain homeostasis occur in the healthy human brain during exposure to acute hypoxia.
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Introduction
Normal brain function requires a stable microenviron-
ment with regard to pH, oxygen and glucose delivery.
The brain has a number of adaptive mechanisms to
keep this environment relatively stable even with
major changes in external factors.
In this study, we investigated the eﬀect of a poikilo-
capnic hypoxic challenge (10% fraction of inspired O2
(FiO2)) on the cerebral energy metabolism in 23 young
healthy males using non-invasive magnetic resonance
imaging (MRI). In poikilocapnic hypoxia the CO2
blood content is not controlled but ﬂuctuate freely
and will decrease during hypoxia due to increased ven-
tilation, contrary to isocapnic hypoxia where CO2 is
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added to the hypoxic air to account for wash out of
CO2 from increased ventilation.
Regulation of brain perfusion is one of the most
important adaptive mechanisms employed to secure
the brain during various circumstances. In acute hyp-
oxia, increased brain perfusion compensates for reduc-
tion of the delivery of oxygen from the blood. Kety and
Schmidt1 found a 35% increase in global cerebral blood
ﬂow (CBF) during inhalation of air with a 10% fraction
of O2 (FiO2) but found no signiﬁcant change in the
global cerebral metabolic rate of oxygen (CMRO2),
despite deﬁnite mental changes.
Whereas the CBF increase during hypoxic exposure
is well known,2 uncertainty exists regarding the
concomitant change in CMRO2. New MRI methods
allow non-invasive measurement of mean CMRO2,
i.e. the brain’s total oxygen consumption divided by
the total brain volume, based on measurement of the
concentration of deoxyhemoglobin in the sagittal sinus
combined with measurement of total blood ﬂow to the
brain and Fick’s principle. Using such a technique, two
studies have reported a slight but signiﬁcant increase in
CMRO2 during a hypoxic challenge.
3,4 On the con-
trary, studies using Kety-Schmidt techniques and
blood samples found no change in CMRO2.
1,5,6
Cerebral lactate release increases during hypoxia,
and lactate contributes up to 9% of total cerebral
energy turnover during hypoxia.7 Through the use of
two-photon laser-scanning microscopy in rat brain
slices, it has been shown that hypoxic O2 levels enhance
the glycolytic rate of the brain.8 Concomitantly, astro-
cyte-mediated vasodilation is mediated by extracellular
lactate and prostaglandin E2 (PGE2) accumulation.9 In
addition, lactate, via its action on a speciﬁc lactate
receptor (GPR81), may inhibit cAMP generation, caus-
ing a slowing of glycolytic rate when the lactate con-
centration rises.10 Furthermore, lactate may act as a
volume transmitter, regulating CBF and the brain
energy turnover of large ensembles of neurons.11 It is
also known that severe ischemia, as observed in stroke,
results in local release of the excitatory neurotransmit-
ter glutamate. This glutamate release, which constitutes
an excitotoxic mechanism, enhances neural activity and
is detrimental for tissue survival.
During hypoxia, ventilation rate will increase and
cause hypocapnia, which also has an eﬀect on the cere-
bral metabolism. However, the reported eﬀect of hypo-
capnia is also diverse. A study on patients with cerebral
vascular disease showed no conclusive result,12 and a
study of healthy humans reported a small but non-sig-
niﬁcant increase in CMRO2 during hypocapnia.
13
In this study, we used magnetic resonance proton
spectroscopy (MRS) to investigate whether hypoxia-
induced changes in CBF and CMRO2 are related to
concomitant changes in cerebral lactate, creatine (Cr)
and glutamate levels. By MRS it is possible to concur-
rently measure lactate, Cr, N-acetylaspartate (NAA) and
glutamate concentration non-invasively. We expect
increased cerebral lactate production if the oxygen deliv-
ery to the brain is suﬃciently reduced during hypoxia.
Phosphocreatine (PCr) and Cr work as energy reserve as
ATP can rapidly be produced from creatine kinase.
Glutamate is an excitatory neurotransmitter and is asso-
ciated with neuronal activity. Measurements of lactate,
Cr and glutamate along with CBF and CMRO2 make it
possible to get a comprehensive picture of the cerebral
metabolism non-invasively.
Based on published results, we expected to ﬁnd no
change or a slight increase in CMRO2 and an increase
in lactate concentration. The eﬀect on glutamate and
Cr is not known, although we suspect a possible inter-
action between energy metabolism and these
metabolites.
Methods
We included 23 young, healthy males (mean age:
27.4 years, range: 18–40 years). The study was con-
ducted as part of a larger project investigating the
eﬀect of erythropoietin on the cerebral metabolism.
The study was approved by the Danish National
Committee on Health Research Ethics (h-4-2012-167)
and was conducted according to the Declaration of
Helsinki. All subjects gave written informed consent
prior to participation.
All scans were performed on a Philips 3T Achieva
MRI scanner (Philips Medical Systems, Best, The
Netherlands) using a 32-channel phase array head coil.
The subjects were scanned during normoxia for
approximately 60min, followed by a 40 min hypoxia
period. During hypoxia, the subjects were ﬁtted with
a mouthpiece connected by a reservoir balloon to a
gas cylinder delivering 10% O2 in nitrogen. No
rebreathing was possible. The MR-compatible system
did not allow us to control the level of CO2.
Arterial blood gas was sampled through an arterial
catheter inserted in the radial artery to monitor arterial
oxygen saturation (SaO2). If the arterial saturation fell
under 60%, the subjects were asked to increase their
breathing rate for safety reasons. Samples were drawn
immediately before switching to hypoxia; seven times
during hypoxia at 1, 2, 3, 5, 10, 20 and 32min after the
start of hypoxia; and once 3min after hypoxia, during
recovery. Immediately after they were taken, the sam-
ples were analyzed for SaO2, O2 pressure (PaO2), CO2
pressure (PaCO2), hematocrit, glucose, hemoglobin and
lactate concentrations by blood gas analysis
(Radiometer ABL800 Flex, Radiometer, Copenhagen,
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Denmark). Arterial oxygen concentration (CaO2) was
calculated from SaO2, PaO2 and hemoglobin levels and
includes both the freely diluted oxygen and the oxygen
bound to hemoglobin. Measurements at 20 and 32min
were carefully temporally matched with MRI measure-
ments of MRS and CMRO2. The eﬀect of hypoxia on
the blood content presented in the result section and
Table 1 is from blood samples taken after approxi-
mately 32min of hypoxia.
The arterial saturation was also measured continu-
ously by pulse oximetry. Electrocardiography was rec-
orded during the whole scan with the MRI scanner’s
accessory hardware.
MRI protocol
MRI methods were used to estimate global mean CBF,
CMRO2 and regional metabolite concentrations in the
visual cortex.
CMRO2 can be computed by Fick’s Principle:
CMRO2 ¼ Ca  CBF  ðSaO2  SvO2Þ ð1Þ
where SaO2 and SvO2 are the arterial and venous
oxygen saturation, respectively, and Ca is the oxygen
concentration (mmol/L) and was calculated for
each subject from the hemoglobin concentration.
The arterial saturation was measured by blood
sampling and the venous saturation was measured in
the sagittal sinus by susceptometry-based MRI ima-
ging (SBO).
CBF was measured by phase-mapping techniques in
the internal carotid arteries and in the vertebral arteries.
CBF and SvO2, from which CMRO2 is quantiﬁed, were
measured during normoxia and after approximately
32min of hypoxia. SvO2 was also measured during
the transition from normoxia to hypoxia over a
period of 3min.
Metabolite concentrations were measured in the
visual cortex by proton MRS. MRS was acquired
over 12min during normoxia and again after approxi-
mately 20min hypoxia.
Anatomical scans were recorded to estimate
brain size for normalizing functional data. Brain
mass was estimated from grey and white volume seg-
mented by FSL (FMRIB Software Library, Oxford
University, Oxford, UK) functions (FAST) and assum-
ing brain density to 1.05 g/mL.
The timing of the MRI measurements can be seen in
Figure 1.
CMRO2
Recently, new MRI techniques have been developed to
measure the oxygen saturation of the blood leaving the
brain in the sagittal sinus. This, in combination with
measurements of CBF, makes it possible to calculate
CMRO2 using Fick’s Principle (equation 1).
In this study, we used susceptometry-based oxim-
etry.14 Susceptibility maps ð Þ were created with a
dual-echo gradient-echo sequence (1 slice, FOV ¼
224  176mm2, voxel size ¼ 0:5  0:5  5mm3,
TE1 ¼ 7:00ms, TE2 ¼ 20:29ms, flip angle ¼ 30, 10
repeated measures) and modulus, real and imaginary
complex values from both echoes were saved. The ima-
ging slice was placed orthogonal to part of the sagittal
sinus parallel to the B0-magnetic ﬁeld (Figure 2(a)).
Susceptibility maps were computed by subtracting
phase-value maps corresponding to the two images gen-
erated with the short- and long-echo times. The suscep-
tibility maps were automatically unwrapped as
described by Goldstein et al.15 Further unwrapping
was performed manually if necessary.
SBO utilizes the diﬀerence in magnetic susceptibility
between intravascular blood and the surrounding tissue
to estimate saturation. The surrounding tissue is
assumed to have the same susceptibility as fully oxyge-
nated arterial blood. The diﬀerence in susceptibility can
be related to saturation by an exact theoretical equa-
tion, where blood vessels are modeled as long paramag-
netic cylinders located parallel with the static magnetic
ﬁeld, as described in equation (2)16
Figure 1. Timing of the measurement of parameters during
MRI. Survey scans, anatomical measurements, cerebral blood
flow, susceptometry-based oximetry and MR spectroscopy were
recorded during the initial 60min of normoxia. After 60min, the
subjects started to inhale 10% FiO2 hypoxic air. After 20min of
hypoxic exposure, the MR spectroscopy measurements were
repeated. After 32min, the recording of CBF and SBO was
repeated under hypoxic exposure.
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where ss xð Þ represents the phase values from the sagit-
tal sinus, tissueð yÞ represents the phase values from the
surrounding tissue,  is the angle between the sagittal
sinus and the B0 ﬁeld, Hct is the hematocrit level, do
is the susceptibility diﬀerence between fully deoxyge-
nated blood and fully oxygenated blood and oxy is
the susceptibility diﬀerence between fully oxygenated
erythrocytes and water. Diﬀerent values for do
have been suggested, ranging from 4  0:18 ppm17 to
4  0:27 ppm.18 This study used do ¼ 4  0:27 ppm
andoxy ¼ 4  ð0:008Þ ppm as suggested by investi-
gations of freshly drawn human blood.19
The diﬀerence in susceptibility between venous
blood and tissue has previously been calculated by
drawing a region of interest (ROI) in the sagittal
sinus and in the surrounding tissue. The surrounding
tissue has uniform susceptibility and therefore should
ideally have the same phase values. However, because
of magnetic ﬁeld inhomogeneities, this is not the case.
The phase values in the tissue ROI therefore depend on
its location. Previously, this has been addressed by ﬁt-
ting a second-order polynomial plane model to the
tissue and subtracting the plane to correct for inhomo-
geneities or by high-pass ﬁltering to remove the low-
frequency variation in inhomogeneity.20 This study
applied a thin-plate spline model (TPS)21 to ﬁt the
tissue phase values. TPS is more ﬂexible than a
second-order polynomial and can correct for larger
inhomogeneities. Control points from the tissue sur-
rounding the sagittal sinus were used to compute the
TPS. By interpolating the TPS values to cover the sagit-
tal sinus, the susceptibility diﬀerence between venous
blood and tissue, ss xð Þ  tissueð yÞ
  can be found by
subtracting the interpolated values for the same ROI
from the thin-plate spline model from the phase values
in the ROI covering the sagittal sinus, ss xð Þ  tpsð xÞ
 .
This process eliminates the need to draw a tissue ROI
and concurrently corrects for ﬁeld inhomogeneities.
Example of correction by TPS is illustrated in
Figure 2(c–e).
The value that appeared most often, the mode, in the
inhomogeneity-corrected phase values of all the voxels
in the ROI covering the sagittal sinus was found and
used to calculate the oxygen saturation. The mode is
used rather than the mean because the values might not
be normally distributed as a result of partial-volume
contamination. Voxels at the edge of the sagittal sinus
will contain tissue from outside the sagittal sinus, which
will reduce the susceptibility of the voxel compared to
voxels containing only blood. This will skew the distri-
bution and aﬀect the mean of the values. However, the
mode will be unaﬀected by this skewing of the distribu-
tion. An example of the distribution of SvO2–values
calculated from voxel in the ROI with the mean
Figure 2. (a) Sagittal and coronal view of angiography highlighting the sagittal sinus with the imaging plane visualized. (b) Part of brain
covering the sagittal sinus used for calculating SvO2. (c) Phase-difference map with region of interest (ROI) in the sagittal sinus and
basis function centers located in surrounding tissue used for calculating thin plate spline model (TPS). (d) Calculated TPS model. (e)
Phase-difference map corrected with TPS. The field inhomogeneity is rectified and the tissue surrounding the sagittal sinus is now close
to zero. (f) Example of distribution of SvO2–values from each voxel from the 10 repeated measurements in the ROI for one subject.
The mode of this distribution is slightly higher than the mean.
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and the mode is illustrated on Figure 2(f). If there is no
partial-volume contamination, the values will be nor-
mally distributed and the mean and mode will be equal.
The mode was calculated by ﬁtting a kernel dens-
ity function to the distribution of the phase values of
all the voxels in the ROI from the 10 repeated
measures.
All processing was performed using Matlab
(Mathworks, Natick, MA, USA) scripts developed in
house.
Total cerebral blood flow
The global mean CBF was calculated by measuring the
velocity in the carotid and vertebral arteries using a
phase-encoding technique (1 slice, FOV ¼ 240
240mm2, voxelsize ¼ 0:75 0:75 8mm3, TE ¼
7:33ms, TR ¼ 27:63ms, flipangle ¼ 10, 10 repeated
measures, non-gated, velocityencoding ¼ 100cm=s).
The imaging slice was placed orthogonal to the
arteries. CBF was calculated by measuring the mean
velocity and cross-sectional area of each of the four
feeding arteries. Processing was performed using in-
house Matlab scripts.
The cerebral delivery of O2 (CDO2) was calculated
by multiplying CBF by the arterial oxygen
concentration.
Magnetic resonance spectroscopy
Magnetic resonance spectroscopy was performed to
measure the concentration of total creatine (tCr), i.e.
PCr and Cr; NAA; lactate and glutamate. A water-sup-
pressed point-resolved spectroscopy (PRESS) pulse
sequence was used (TR ¼ 5000ms, TE ¼ 36:5ms,
voxelsize ¼ 30 35 30mm3, 64 acquisitions, total
duration 6min34s). The water signal was also measured
and used as an internal standard for quantiﬁcation.22
The voxel was located in the visual cortex covering the
calcarine ﬁssure (Figure 3(a)). The entire voxel was
located inside brain tissue to avoid signal from subcuta-
neous fat, which has the same frequencies as lactate and
could potentially confound the quantiﬁcation of the
lactate peak. Example of spectra measured during nor-
moxia and hypoxia can be seen in Figure 3(b). Two
spectra were recorded during normoxia and two spectra
were recorded during hypoxia, all with visual stimula-
tion. Visual stimulation was provided via video goggles
(NordicNeuroLab, Bergen, Norway, 800  600
pixels, refresh rate 85Hz) presenting an 8Hz ﬂickering
checkerboard to evoke maximal neuronal activity and
stimulate lactate production.
Post-processing and quantiﬁcation of the spectra
were performed with LCModel (LCModel (Version
6.3-1F), Toronto, Canada). Absolute concentrations
(b)
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Figure 3. (a) Location of MR spectroscopy voxel ðvoxel size ¼ 30 35 30mm3Þ used to measure various metabolite concen-
trations. The voxel is located in the visual cortex in the occipital lobe covering the calcarine fissure. (b) Example of spectra measured
during normoxia and hypoxia. The peak used for quantifying N-acetylaspartate (NAA), glutamate, lactate and total creatine con-
centrations (tCr) are visible.
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of metabolites were estimated using the unsuppressed
water signal as the reference signal. Mean concentra-
tions were calculated from the two spectra measured
during normoxia and the two spectra measured
during hypoxia.
Anatomical scan
High-resolution anatomical scans were obtained with
a 3D T1-weighted turbo ﬁeld echo sequence (150
slices, FOV ¼ 241 180 165mm3, voxel size ¼
1:09 0:81 1:1mm3, TE ¼ 2:78ms, TR ¼ 6:9ms,
flipangle ¼ 9).
Statistics
The signiﬁcance of the eﬀect of hypoxia on the mea-
sured parameters was calculated using a paired
Student’s t-test (Table 1).
To test the eﬀect of the degree of hypoxia on the
measured parameters a mixed linear regression model
was used. The measured parameter was modeled as the
response variable, CaO2 was modeled as a ﬁxed vari-
able and subject grouping was modeled as a random
variable to account for between-subject variability.
CaO2 was used as the ﬁxed parameter, as this is the
total amount of oxygen available in the arterial
blood and therefore indicates the degree of hypoxia in
the tissue.
Both hypoxemia and hypocapnia are suspected to
have an eﬀect of the measured parameters. In order
to test for the signiﬁcance of each eﬀect a similar
mixed model but with both CaO2 and PaCO2 as ﬁxed
parameters were also calculated (Table 2).
To test for a possible eﬀect of lactate concentration on
CBF, a mixed model was used with CBF as the response
variable; lactate concentration, PaCO2 and CaO2, as
ﬁxed variables and subject grouping as a random vari-
able. Oxygen and CO2 are known agents in controlling
CBF and are therefore included in the model. Lactate
concentration, PaCO2 and CaO2 were orthogonalized
by whitening transformation before entering the model
to avoid co-linearity. The model therefore tests for an
independent eﬀect of lactate on CBF.
Statistical calculations were performed using the
Matlab statistics toolbox.
Results
During hypoxia, CaO2 decreased signiﬁcantly
(p5 106) with 20.5% from 8.5  0.6mmol/L to 6.8
 13mmol/L. SaO2 decreased signiﬁcantly (p5 106)
from 98.0  0.5% to 78.4  11.2%. PaO2 decreased
signiﬁcantly (p5 106) with 62.2% from 14.1
 1.4 kPa to 5.3  13 kPa. SvO2 decreased signiﬁcantly
(p5 106) from 68.5  7.6% to 48.7  11.0%. PaCO2
decreased signiﬁcantly (p5 106), by 24.3% from
5.5  0.5 kPa to 4.1  0.8 kPa.
Heart rate increased signiﬁcantly, by 20.9%
(p5 106). Mean arterial pressure (MAP) did not
change (p¼ 0.17). Hemoglobin concentration increased
signiﬁcantly, by 1.2% (p¼ 0.035). Blood glucose con-
centration decreased signiﬁcantly, by 8.2% (p5 104).
Blood lactate did not change signiﬁcantly (p¼ 0.38).
CDO2 decreases signiﬁcantly (p¼ 0.01) with 12.4%.
CBF increased near-signiﬁcantly (p¼ 0.058) with
15.5% from 58.2  6.5mL/100 g/min during normoxia
to 67.1  22.8mL/100 g/min during hypoxia. The
arteriovenous O2 saturation diﬀerence (A-V O2) did
not change between normoxia and hypoxia (p¼ 0.89).
CMRO2 increased signiﬁcantly (p¼ 0.035) with 8.5%
from 148.9  40.3 mmol/100 g/min during normoxia to
161.6  53.7 mmol/100 g/min during hypoxia. The vari-
ability in CMRO2 increased during hypoxia.
NAA concentration showed no change between nor-
moxia and hypoxia (p¼ 0.36). Glutamate concentra-
tions increased signiﬁcantly (p5 104) with 4.7%,
cerebral lactate increased signiﬁcantly (p5 106) with
180.3% and tCr concentration decreased signiﬁcantly
(p5 103) with 15.2%.
Figure 4 shows the CBF, A-V O2, the calculated
CMRO2, the metabolites derived from MRS and
blood lactate with the corresponding arterial oxygen
concentration. For one subject, the MRS measurement
failed for technical reasons; this subject was excluded.
Figure 4(a) shows a signiﬁcant negative correlation
ð p5 106) between CBF and arterial oxygen concen-
tration. However, for some subjects with high oxygen
concentration during hypoxia, CBF decreased slightly.
Figure 4(b) shows no signiﬁcant correlation between
A-V O2 and arterial oxygen concentration (p¼ 0.095).
CMRO2 (Figure 4(c)) shows a signiﬁcant negative cor-
relation with arterial oxygen concentration (p¼ 0.004).
NAA concentration (Figure 4(d)) did not change
with arterial oxygen concentration (p¼ 0.18).
Glutamate concentration (Figure 4(e)) was signiﬁcantly
negatively correlated (p¼ 0.004) with arterial oxygen
concentration.
Cerebral lactate concentration (Figure 4(f)) showed
a signiﬁcant negative correlation (p5 106) with arter-
ial oxygen concentration. In one subject, the lactate
peak was not detectable during hypoxia, and this data
point was removed from the analysis. The concurrently
measured blood lactate (Figure 4(h)) level did not cor-
relate with arterial oxygen concentration (p¼ 0.089).
tCr concentration (Figure 4(g)) was signiﬁcantly
positively correlated (p¼ 0.002) with arterial oxygen
concentration. The results are summarized in Table 1.
Results from model separating the eﬀects of oxygen
and CO2 on the cerebral metabolism are summarized in
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Table 2. CDO2 was signiﬁcantly positively correlated
with PaCO2 (p5 105) and not CaO2 (p¼ 0.37). CBF
was signiﬁcantly negatively correlated with CaO2
(p5 106) and signiﬁcantly positively correlated with
PaCO2 (p5 103). A-V O2 was signiﬁcantly positively
correlated with CaO2 (p5 106) and signiﬁcantly nega-
tively correlated with PaCO2 (p5 106). CMRO2 was
signiﬁcantly negatively correlated with CaO2 (p¼ 0.007)
and not PaCO2 (p¼ 0.70). Glutamate was signiﬁcantly
negatively correlated with PaCO2 (p5 103) and not
CaO2 (p¼ 0.63). Cerebral lactate was signiﬁcantly nega-
tively correlated with CaO2 (p5 106) and PaCO2
(p5 106). tCr concentration (Figure 4(g)) was signiﬁ-
cantly positively correlated with PaCO2 (p¼ 0.004) and
not CaO2 (p¼ 0.13).
Model testing correlation between CBF and decorre-
lated lactate concentration, PaCO2 and CaO2, showed
signiﬁcant positive correlation for PaCO2 (weight¼ 6.0,
p5 104) and lactate (weight¼ 2.8, p¼ 0.044) and a
signiﬁcant negative correlation for CaO2 (weight¼ –
11.8, p5 106). R2 for the model was 0.78.
Discussion
The brain’s reaction to acute hypoxia is interesting from
both a physiological and pathophysiological point of
view, but comprehensive study of the brain’s reaction
is diﬃcult and often involves invasive measurements.
However, by using combined MRI and MRS, fast and
non-invasive measurements are now possible. To our
knowledge, metabolite concentrations in the brain
during hypoxia have not yet been measured using MRS.
We found evidence for metabolic changes, not only a
CBF increase, during an acute hypoxic challenge in
healthy young subjects.
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Figure 4. Correlations between arterial oxygen concentration (CaO2) during 10% FiO2 hypoxic challenge and (a) cerebral blood
flow (CBF), (b) arteriovenous O2 saturation difference (A-V O2), (c) cerebral metabolic rate of oxygen (CMRO2); and concentrations
of (d) N-acetylaspartate (NAA), (e) glutamate, (f) cerebral lactate, (g) creatine and phosphocreatine (tCr) in the brain measured with
MR spectroscopy; and (h) lactate concentration in the blood.
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Blood gasses
At normoxia, the venous saturation was on average
(68.5%) slightly higher compared to other studies
using the same or diﬀerent techniques, which normally
reports saturations between 60% and 65%.14,23 We
believe the higher values we measure could be caused
by systematical bias from our scanner due to ﬁeld
inhomogeneity. We try to correct for inhomogeneities,
however, a small bias could still be present. We believe
the bias to be the same during normoxia and hypoxia,
and therefore will not aﬀect the result in a paired
comparison.
The arterial oxygen saturation responses to hypoxia
were heterogeneous (Figure 5(a)). Some subjects had an
arterial saturation of more than 90% during hypoxia.
By contrast, some subjects had a pronounced decrease
in arterial oxygen saturation, to less than 60%. Subjects
with high arterial saturation had the largest decrease of
PaCO2 (Figure 5(b)), which we believe is due to diﬀer-
ent ventilator responses where these subjects had more
pronounced hyperventilation.
We tried to diﬀerentiate between the eﬀects of hyp-
oxemia and those of hypocapnia by including both CaO2
Table 1. Summary of the results and statistics.
Normoxia Hypoxia
Absolute
change
Percent
change T-test p value
Regression
p value
Blood content
CaO2 (mmol/L) 8.5  0.6 6.8  1.3 –1.7 –20.5 5 106a
PaO2 (kPa) 14.1  1.4 5.3  1.3 –8.8 –62.2 5 106a 5 106a
SaO2 (%) 98.0  0.5 78.4  11.2 –19.6 –20.0 5 106a 5 106a
SvO2 (%) 68.5 7.6 48.7 11.0 –19.9 –29.0 5 106a 5 106a
PaCO2 (kPa) 5.5  0.5 4.1  0.8 –1.3 –24.3 0.002a 0.18a
Hemoglobin (mmol/L) 8.7  0.6 8.8  0.6 0.1 1.2 0.035a 0.053
Glucose (mmol/L) 5.9  0.6 5.4  0.4 –0.5 –8.2 5 104a 0.014a
Blood lactate (mmol/L) 1.0  0.2 1.0  0.4 0.05 4.9 0.38 0.089
Hemodynamics
Heart Rate (bpm) 57.0  9.0 69.0  10.2 11.9 20.9 5 106a 5 106a
MAP BP (mmHg) 76.6  8.4 75.1  8.2 –1.5 –0.02 0.17 0.024
Cerebral metabolism
CDO2 (mmol/100 g/min) 494.3 54.7 433.2  99.8 –61.1 –12.4 0.01a 0.73
CBF (mL/100 g/min) 58.2  6.5 67.2  22.8 9.0 15.5 0.058 5 106a
A-V O2 (%) 29.5  7.7 29.8  10.3 0.0 0.9 0.89 0.095
CMRO2 (mmol/100 g/min) 148.9  40.3 161.6  53.7 12.7 8.5 0.035a 0.004a
NAA (mmol/L) 7.9  0.4 7.8  0.7 –0.1 –1.4 0.36 0.18
Glutamate (mmol/L) 6.4  0.4 6.7  0.5 0.3 4.7 5 104a 0.004a
Cerebral lactate (mmol/L) 0.4  0.2 1.2  0.3 0.8 180.3 5 106a 5 106a
tCr (mmol/L) 3.1 0.3 2.6  0.6 –0.5 –15.2 5 103a 0.002a
aA statistically significant change (p< 0.05). CaO2: arterial O2 concentration; PaO2: arterial O2 pressure; SaO2: arterial saturation; SvO2: venous
saturation; PaCO2: arterial CO2 pressure; MAP BP: mean arterial blood pressure; CDO2: cerebral O2 delivery; CBF: cerebral blood flow; A-V O2:
arteriovenous O2 saturation difference; CMRO2: cerebral metabolic rate of O2; NAA: N-acetylaspartate; tCr: creatine and phosphocreatine.
Table 2. Summary of statistics from mixed linear model with
CaO2 and PaCO2 as fixed parameters.
CaO2
weight
CaO2
p value
PaCO2
weight
PaCO2
p value
Cerebral metabolism
CDO2 (mmol/
100 g/min)
7.2 0.37 55.3 5105a
CBF (mL/100 g/min) 10.5 5106a 6.9 5103a
A-V O2 (%) 0.03 5104
a 0.041 5104a
CMRO2 (mmol/
100 g/min)
8.8 0.007a 1.6 0.70
NAA (mmol/L) 0.073 0.21 0.019 0.82
Glutamate
(mmol/L)
0.016 0.63 0.18 5103a
Cerebral lactate
(mmol/L)
0.15 5106a 0.31 5106a
tCr (mmol/L) 0.080 0.13 0.23 0.004a
aA statistically significant change (p< 0.05). CDO2: cerebral O2 delivery;
CBF: cerebral blood flow; A-V O2: arteriovenous O2 saturation differ-
ence; CMRO2: cerebral metabolic rate of O2; NAA: N-acetylaspartate;
tCr: creatine and phosphocreatine.
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and PaCO2 in a linear regression model. The Pearson’s r
correlation between CaO2 and PaCO2 is 0.20, which we
believe is low enough for CaO2 and PaCO2 to be
included as independent variables in the model.
Total cerebral blood flow
The observation of increased CBF during poikilocapnic
hypoxia is in good agreement with published results.
We found a negative correlation between CBF and
CaO2 and positive correlation with PaCO2 as expected.
Several studies have reported hypoxia-induced
increases in CBF using diﬀerent modalities.1,2,5,6,24
The standard deviation of the CBF was higher during
hypoxia because of the subjects’ diﬀerent ventilatory
responses. By contrast, in subjects with high arterial
saturation and low PaCO2 during hypoxia, CBF
decreased slightly, probably due to hypocapnic-induced
vasoconstriction (Figure 3(b)). Hypocapnic vasocon-
striction during hypoxia has also been previously
reported.3,25
CMRO2
The eﬀect of hypoxia on CMRO2 is less established
than the eﬀect on CBF and conﬂicting results have
been published (summarized in Table 3). We found a
signiﬁcant increase of 8.5%. CMRO2 was signiﬁcantly
correlated with CaO2 and not with PaCO2. The global
baseline CMRO2 measured was in good agreement with
reported values obtained using diﬀerent tech-
niques.5,26–28 The standard deviation of our CMRO2
measurements increased during hypoxia, most likely
because of the variable ventilatory responses.
The ﬁrst study that examined CMRO2 during the
inhalation of a hypoxic gas mixture was conducted by
Kety and Schmidt,1 who found a non-signiﬁcant 6%
decrease in CMRO2 when subjects inhaled a 10%
FiO2 gas mixture. A subsequent study using a similar
technique found a non-signiﬁcant 4% increase in
CMRO2 during the breathing of 6.9–7.5% FiO2.
5
A recent study on progressive hypoxia (90%, 80%
and 70% arterial saturation) using invasive measure-
ments also found no change in CMRO2.
6
Recently, two MRI studies have reported a slight but
signiﬁcant 5.0% increase in CMRO2 during the inhal-
ation of moderately hypoxic gas for 18min (14% FiO2)
3
and a signiﬁcant increase in CMRO2 of 18% after a two-
day stay at an altitude of 3800 meters (approximately
12.5% FiO2) and descent while breathing a hypoxic gas
mixture.29 The method for measuring CMRO2 in these
studies used an MRI technique that relied on the T2
relaxation of blood,30 in contrast to the method used
in this study, susceptibility maps. These results indicate
that our ﬁnding is independent of the MRI method used.
Diﬀerences in methodology, e.g. the variability of
FiO2, make direct comparisons to other studies diﬃ-
cult. Severe hypoxia may yield a diﬀerent response
compared to moderate hypoxia. If the hypoxia becomes
too severe, CMRO2 must decrease because of insuﬃ-
cient oxygen delivery to the blood and hence the brain.
Magnetic resonance spectroscopy
Lactate metabolism. Studies have reported increased net
lactate eﬄux from the human brain during hypoxia
using tracer methods.7 Consistent with previous results,
we found that acute hypoxia increased the concentra-
tion of lactate in the brain. We found correlation on
increased cerebral lactate with decrease in both CaO2
and PaCO2. We did not observe changes in blood lac-
tate concentration resulting from increased lactate
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Figure 5. (a) Arterial saturation for each subject during 10% FiO2 hypoxic challenge. Large variability was observed between
subjects. Some subjects seemed to be able to compensate almost completely for the inhalation of hypoxic air via pronounced
hyperventilation and had almost no decrease in arterial saturation. By contrast, saturation in some subjects decreased to less than
60%. On average, the saturation decreased to 78% after 20min of hypoxia, when the mean saturation reaches a plateau. (b) Arterial
oxygen saturation and corresponding arterial CO2 pressure measured after 32min of hypoxia. Subjects with a small decrease in
arterial saturation had more pronounced hyperventilation and therefore a larger reduction in CO2.
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production in the muscles, as observed in other stu-
dies.7 The reason for this lack of change is probably
the limited muscle activity of the subjects, as they were
lying motionless in the scanner when inhaling the hyp-
oxic air. We corrected for the amount of blood lactate
in the spectroscopic voxel and found a maximum con-
tribution of 7%; therefore, peripherally produced lac-
tate cannot explain the increase in cerebral lactate.
Lactate is an important energy source during hyp-
oxic, ischemic or hypoglycemic injury and during stress
and may have neuroprotective properties.31 In rat
models, increased lactate levels are protective against
excitotoxicity from increased glutamate levels.32
Increased lactate levels provide a source for fast
energy production during increased glutamatergic syn-
aptic activity. It has been shown that the neuroprotec-
tive eﬀect of lactate is not mediated by improved
glutamate uptake in animals.33
Glutamate. It is diﬃcult to diﬀerentiate between the con-
centrations of glutamate and glutamine measured by
MRS in 3T MR-scanner in humans in vivo. For this
reason, the glutamate concentrations reported also
includes glutamine concentrations. In addition, the spec-
troscopic level of glutamate does not necessarily relate to
glutamatergic neurotransmission because extracellular
and vesicular glutamate only represents a small fraction
of the total amount of brain glutamate. It is likely that
glutamate not encapsulated in vesicles is more MR-
visible relative to its molar fraction. Therefore, the inter-
pretation of the increased concentration is associated
with some uncertainty, and studies should be repeated
at higher ﬁeld strength. However, glutamate is an exci-
tatory neurotransmitter, and the increase observed
during hypoxia could be an indication of increased neur-
onal activity. We found the increase in glutamate to pri-
marily be correlated with decrease in PaCO2, which
support previously published results on increased neur-
onal activity during hypocapnia.34
The increased glutamate concentration could result
from reduced astrocyte activity and reuptake and a
higher level of MR-visible glutamate in the synaptic
cleft due to altered energy metabolism, as has previ-
ously been proposed.35
PCr and Cr. On average, we found a signiﬁcant decrease
in tCr; however, the subjects had heterogeneous
responses. Some subjects showed a large decrease in
concentration, whereas others showed no change.
Increase in tCr concentration was primarily driven by
decrease in PaCO2.
To our knowledge Cr concentration has not prior
been measured in humans during hypoxia or hypocap-
nia. In animals studies the published eﬀect of hypocap-
nia on Cr or PCr are diverse. Study has shown
hypocapnia to decrease PCr in cats,36 on the contrary
a study on rats found no change.37
Previous studies on hypoxia have found a decrease in
PCr in animals.38,39 In moderate hypoxia, the decrease in
PCr is not associated with decreased ATP concentra-
tion.38 However, in severe hypoxia with near-complete
depletion of PCr, the ATP concentration also decreases.39
High Cr and PCr concentrations may have a neuro-
protective eﬀect against ischemic and hypoxic injury in
animals.40 High PCr concentrations enable increased
CK-mediated catalysis of ATP and could underlie the
neuroprotective properties.40 Using 3T MRI in vivo in
humans, it is not possible to diﬀerentiate between PCr
and Cr concentrations measured by MRS. However, a
shift towards increased CK-mediated ATP catalysis
could potentially occur as a manifestation of hypoxia
and a coping mechanism. Although these results are
ambiguous, the change in tCr concentration is an indi-
cation of altered energy metabolism.
Table 3. Previously published results of cerebral metabolic rate of oxygen, glucose and lactate during hypoxia.
Study Findings
Number
of subjects Methods Comment
Kety and Schmidt1 CMRO2 7 Kety-Schmidt 10% FiO2
Cohen et al.5 CMRO2 9 Kety-Schmidt 6.9–7.5% FiO2
"CMRglu
"CMRlac
Xu et al.3 "CMRO2 16 MRI 14% FiO2
Smith et al.4 "CMRO2 26 MRI Stay at high altitude (3800m)
Ainslie et al.6 CMRO2 10 Doppler ultrasound;
blood sampling.
90%–70% SaO2
CMRglu
CMRlac
: denotes no change; ": denotes an increase.
Vestergaard et al. 1055
Cerebral energy metabolism
In agreement with previously reported results, we found
that during moderate-to-severe hypoxia in healthy
humans, CBF increased and tended to compensate for
hypoxemia.
In addition, we found signiﬁcantly increased
CMRO2, indicating elevated oxidative energy metabol-
ism. It may seem counterintuitive to observe an increase
in CMRO2 during hypoxia. However, even though
oxygen delivery to the brain decreased slightly, the
availability of oxygen in the brain is still suﬃcient to
allow an increase in CMRO2. We speculate that the
increased lactate concentration indicates further
energy demand met by anaerobic glycolysis. An
increased glutamate concentration could suggest
increased neuronal stimulation or activity, which
could be driven by the hypocapnia. Hypocapnia has
been suggested as the reason for increased CMRO2
during poikilocapnic hypoxia by Smith et al.,29 who
also reported increased CMRO2. The reported eﬀects
of hypocapnia on CMRO2 are diverse. A study of
patients with ischemic cerebrovascular disease showed
no conclusive result,12 and two studies on healthy
humans reported a small but non-signiﬁcant increase
in CMRO2 during moderate normoxic hypocapnia.
41,42
Hypocapnia has been shown to increase the excitability
of neurons,34 which might be associated with the
increased metabolic rate and glutamate concentration
that we observed. Further investigation is needed to
properly determine the eﬀect of acute hypocapnia. The
subjects in the study by Kety and Schmidt1 had mild
hypocapnia compared to those in our study, and subjects
in the studies by Cohen et al.5 and Ainslie et al.6 did not
exhibit a decrease in CO2 pressure, which could explain
the discrepancy in CMRO2 measurements.
We found the increase in CMRO2 to be correlated
with decrease in CaO2 but not with PaCO2. However,
all subjects had decreased PaCO2, and hypocapnia
could still be a factor in the increase in CMRO2.
Increased energy metabolism could be associated
with an increased cerebral metabolic rate of glucose
(CMRglu) and lactate (CMRlac), as shown in a previous
study of acute, 6.9–7.5% hypoxia in humans.1 Studies
in rats have also found increased glucose transport8 and
metabolism after sustained hypoxia.43 Hypocapnia has
also been shown to increase CMRglu in rats44 and in
humans during severe hypocapnia, but not in moderate
hypocapnia.42 A recent study found no change in
CMRglu and CMRlac in humans during progressive
hypoxia (90%–70% SaO2).
6
We found evidence for increased metabolic rate and
neuronal activity. The reason for this is not obvious.
For both hypoxia and hypocapnia there exist publica-
tions that indicate increased metabolic rate, with other
studies indicating no change. The increased metabolic
rate we observe could be a combination of the eﬀects of
increased excitability from hypocapnia and increased
ﬂow from hypoxia.
CBF regulation
CBF is tightly coupled to arterial CO2 and O2 pressure.
Lactate has also been proposed as a regulator of CBF,
with eﬀects mediated through astrocyte-induced vaso-
dilation.11 We found, after decorrelation of the three
parameters, signiﬁcant correlation between CBF and
PaCO2 and CaO2, but also lactate. This indicates
that lactate concentration also has a regulating eﬀect
on CBF.
Limitations
In these young, healthy individuals, ventilatory
responses were highly variable. The large variation in
ventilatory responses could result in diﬀerent metabolic
changes, making it diﬃcult to ﬁnd a decisive
conclusion.
The measurement of global CMRO2 using MRI is a
new technique, and few studies have been published,
especially those that measure saturation outside of the
normal range. A potential source of error is the partial-
volume eﬀect in voxels near the edge of the sagittal
sinus. These voxels contain not only blood but also
tissue, which will lower the susceptibility of the voxel.
We corrected for this by ﬁnding the mode of the voxel
values in the ROI, which is less sensitive to one-sided
outliers than the mean.
Another potential error could result from magnetic
ﬁeld inhomogeneities. We corrected for this by ﬁtting a
thin-plate spline to the brain tissue surrounding the
sagittal sinus and estimating the ﬁeld inhomogeneities
over the sagittal sinus. If there is strong variation
across the sagittal sinus, this correction might not be
suﬃcient. The inhomogeneities did not change
substantially during the scanning sessions; thus, we
believe that the potential error was constant during the
normoxia and hypoxia measurements. We do not believe
that the potential error was systematic between subjects.
Another potential source of error is the use of brain
tissue as a reference value for fully oxygenated blood.
During hypoxia, the susceptibility of the tissue would
be expected to increase because of the less saturated
arterial blood. To test whether this is a problem, we
measured the susceptibility in an ROI in the brain
tissue during the transition period from normoxia to
hypoxia and found no systematic increase. If an increase
in susceptibility in the tissue occurred, the calculated sat-
uration in the sagittal sinus would be overestimated, and
CMRO2 would be underestimated during hypoxia.
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Therefore, this possibility cannot be the reason for the
increased CMRO2 measured during hypoxia.
The problems associated with the absolute quantiﬁ-
cation of brain metabolites using MRS have been previ-
ously discussed.45 As we compared the same subject
between two situations, the problems with absolute con-
centration are mitigated. Hypoxemia in the brain will
change the magnetic properties of the arterial blood
and therefore will change the magnetic ﬁeld in the scan-
ner. This could potentially confound the measured spec-
tra and could potentially explain the diﬀerences in the
metabolite concentrations measured during normoxia
and hypoxia. However, the NAA concentration did
not change, which indicates the absence of a systematic
error caused by changes in the magnetic ﬁeld. The con-
centration of NAA is a marker of neuronal density and
should not change from short periods of inhaling hyp-
oxic air. In addition, the quantiﬁcation of this metabolite
was based on the area under the various peaks, which is
relatively unaﬀected by a change in ﬁeld strength.
Conclusion
The present ﬁndings suggest that the response of the
brain to acute poikilocapnic hypoxia includes not
only an increase in CBF but also an alteration of
energy metabolism.
We found increased cerebral blood ﬂow and
increased CMRO2, suggesting higher oxidative metab-
olism. We found an increase in lactate concentration
and a decrease in tCr concentration, further suggesting
an increase in metabolism. Furthermore, we found an
increase in glutamate concentration, which may indi-
cate higher neural activity.
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